Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Service (Bioanalytical Testing, Method Development and Validation, Stability Testing), By End Use, By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Services
                        1.2.2. End Use
                        1.2.3. Regional scope
                        1.2.4. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in North America
                            1.4.5.2. Data for primary interviews in Europe
                            1.4.5.3. Data for primary interviews in Asia Pacific
                            1.4.5.4. Data for primary interviews in Latin America
                            1.4.5.5. Data for Primary interviews in MEA
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Services outlook
                        2.2.2. End Use outlook
                        2.2.3. Regional outlook
                    2.3. Competitive Insights
Chapter 3. Pharmaceutical Analytical Testing Outsourcing Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Increasing Innovation and product development
                            3.2.1.2. Growing demand for Regulation on safety and quality
                            3.2.1.3. Rising End-users volume
                            3.2.1.4. Pricing strategies
                        3.2.2. Market restraint analysis
                            3.2.2.1. Data insecurity
                            3.2.2.2. Third-party performance
                    3.3. Pharmaceutical Analytical Testing Outsourcing Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
Chapter 4. Pharmaceutical Analytical Testing Outsourcing Market: Services Estimates & Trend Analysis
                    4.1. Services Market Share, 2023 & 2030
                    4.2. Segment Dashboard
                    4.3. Global Pharmaceutical Analytical Testing Outsourcing Market by Services Outlook
                    4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        4.4.1. Bioanalytical Testing
                            4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.1.2. Clinical Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.1.3. Non-Clinical Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.2. Method Development & Validation
                            4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.2.2. Extractable & Leachable Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.2.3. Impurity Method Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.2.4. Technical Consulting Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.2.5. Others Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.3. Stability Testing
                            4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.2. Drug Substance Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.3. Stability Indicating Method Validation Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.4. Accelerated Stability Testing Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.5. Photostability Testing Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.6. Others Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.4. Other
                            4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Pharmaceutical Analytical Testing Outsourcing Market: End Use Estimates & Trend Analysis
                    5.1. End Use Market Share, 2023 & 2030
                    5.2. Segment Dashboard
                    5.3. Global Pharmaceutical Analytical Testing Outsourcing Market by End Use Outlook
                    5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        5.4.1. Pharmaceutical Companies
                            5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.2. Biopharmaceutical Companies
                            5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.3. Contract Research Organizations
                            5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Pharmaceutical Analytical Testing Outsourcing Market: Regional Estimates & Trend Analysis
                    6.1. Regional Market Share Analysis, 2023 & 2030
                    6.2. Regional Market Dashboard
                    6.3. Global Regional Market Snapshot
                    6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
                    6.5. North America
                        6.5.1. U.S.
                            6.5.1.1. Key country dynamics
                            6.5.1.2. Regulatory framework/ reimbursement structure
                            6.5.1.3. Competitive scenario
                            6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
                        6.5.2. Canada
                            6.5.2.1. Key country dynamics
                            6.5.2.2. Regulatory framework/ reimbursement structure
                            6.5.2.3. Competitive scenario
                            6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
                    6.6. Europe
                        6.6.1. UK
                            6.6.1.1. Key country dynamics
                            6.6.1.2. Regulatory framework/ reimbursement structure
                            6.6.1.3. Competitive scenario
                            6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
                        6.6.2. Germany
                            6.6.2.1. Key country dynamics
                            6.6.2.2. Regulatory framework/ reimbursement structure
                            6.6.2.3. Competitive scenario
                            6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
                        6.6.3. France
                            6.6.3.1. Key country dynamics
                            6.6.3.2. Regulatory framework/ reimbursement structure
                            6.6.3.3. Competitive scenario
                            6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
                        6.6.4. Italy
                            6.6.4.1. Key country dynamics
                            6.6.4.2. Regulatory framework/ reimbursement structure
                            6.6.4.3. Competitive scenario
                            6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
                        6.6.5. Spain
                            6.6.5.1. Key country dynamics
                            6.6.5.2. Regulatory framework/ reimbursement structure
                            6.6.5.3. Competitive scenario
                            6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
                        6.6.6. Norway
                            6.6.6.1. Key country dynamics
                            6.6.6.2. Regulatory framework/ reimbursement structure
                            6.6.6.3. Competitive scenario
                            6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
                        6.6.7. Sweden
                            6.6.7.1. Key country dynamics
                            6.6.7.2. Regulatory framework/ reimbursement structure
                            6.6.7.3. Competitive scenario
                            6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
                        6.6.8. Denmark
                            6.6.8.1. Key country dynamics
                            6.6.8.2. Regulatory framework/ reimbursement structure
                            6.6.8.3. Competitive scenario
                            6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
                    6.7. Asia Pacific
                        6.7.1. Japan
                            6.7.1.1. Key country dynamics
                            6.7.1.2. Regulatory framework/ reimbursement structure
                            6.7.1.3. Competitive scenario
                            6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
                        6.7.2. China
                            6.7.2.1. Key country dynamics
                            6.7.2.2. Regulatory framework/ reimbursement structure
                            6.7.2.3. Competitive scenario
                            6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
                        6.7.3. India
                            6.7.3.1. Key country dynamics
                            6.7.3.2. Regulatory framework/ reimbursement structure
                            6.7.3.3. Competitive scenario
                            6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
                        6.7.4. Australia
                            6.7.4.1. Key country dynamics
                            6.7.4.2. Regulatory framework/ reimbursement structure
                            6.7.4.3. Competitive scenario
                            6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
                        6.7.5. South Korea
                            6.7.5.1. Key country dynamics
                            6.7.5.2. Regulatory framework/ reimbursement structure
                            6.7.5.3. Competitive scenario
                            6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
                        6.7.6. Thailand
                            6.7.6.1. Key country dynamics
                            6.7.6.2. Regulatory framework/ reimbursement structure
                            6.7.6.3. Competitive scenario
                            6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
                    6.8. Latin America
                        6.8.1. Brazil
                            6.8.1.1. Key country dynamics
                            6.8.1.2. Regulatory framework/ reimbursement structure
                            6.8.1.3. Competitive scenario
                            6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
                        6.8.2. Mexico
                            6.8.2.1. Key country dynamics
                            6.8.2.2. Regulatory framework/ reimbursement structure
                            6.8.2.3. Competitive scenario
                            6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
                        6.8.3. Argentina
                            6.8.3.1. Key country dynamics
                            6.8.3.2. Regulatory framework/ reimbursement structure
                            6.8.3.3. Competitive scenario
                            6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
                    6.9. MEA
                        6.9.1. South Africa
                            6.9.1.1. Key country dynamics
                            6.9.1.2. Regulatory framework/ reimbursement structure
                            6.9.1.3. Competitive scenario
                            6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
                        6.9.2. Saudi Arabia
                            6.9.2.1. Key country dynamics
                            6.9.2.2. Regulatory framework/ reimbursement structure
                            6.9.2.3. Competitive scenario
                            6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
                        6.9.3. UAE
                            6.9.3.1. Key country dynamics
                            6.9.3.2. Regulatory framework/ reimbursement structure
                            6.9.3.3. Competitive scenario
                            6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
                        6.9.4. Kuwait
                            6.9.4.1. Key country dynamics
                            6.9.4.2. Regulatory framework/ reimbursement structure
                            6.9.4.3. Competitive scenario
                            6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                    7.2. Company/Competition Categorization
                    7.3. Vendor Landscape
                        7.3.1. List of key distributors and channel partners
                        7.3.2. Key customers
                        7.3.3. Key company market share analysis, 2023
                        7.3.4. SGS S.A.
                            7.3.4.1. Company overview
                            7.3.4.2. Financial performance
                            7.3.4.3. Product benchmarking
                            7.3.4.4. Strategic initiatives
                        7.3.5. Labcorp
                            7.3.5.1. Company overview
                            7.3.5.2. Financial performance
                            7.3.5.3. Product benchmarking
                            7.3.5.4. Strategic initiatives
                        7.3.6. Eurofins Scientific
                            7.3.6.1. Company overview
                            7.3.6.2. Financial performance
                            7.3.6.3. Product benchmarking
                            7.3.6.4. Strategic initiatives
                        7.3.7. Pace Analytical Services, Inc.
                            7.3.7.1. Company overview
                            7.3.7.2. Financial performance
                            7.3.7.3. Product benchmarking
                            7.3.7.4. Strategic initiatives
                        7.3.8. Intertek Group Plc
                            7.3.8.1. Company overview
                            7.3.8.2. Financial performance
                            7.3.8.3. Product benchmarking
                            7.3.8.4. Strategic initiatives
                        7.3.9. PPD Inc. (Thermo Fisher Scientific)
                            7.3.9.1. Company overview
                            7.3.9.2. Financial performance
                            7.3.9.3. Product benchmarking
                            7.3.9.4. Strategic initiatives
                        7.3.10. WuXi AppTec
                            7.3.10.1. Company overview
                            7.3.10.2. Financial performance
                            7.3.10.3. Product benchmarking
                            7.3.10.4. Strategic initiatives
                        7.3.11. Boston Analytical
                            7.3.11.1. Company overview
                            7.3.11.2. Financial performance
                            7.3.11.3. Product benchmarking
                            7.3.11.4. Strategic initiatives
                        7.3.12. Charles River Laboratories
                            7.3.12.1. Company overview
                            7.3.12.2. Financial performance
                            7.3.12.3. Product benchmarking
                            7.3.12.4. Strategic initiatives
                        7.3.13. West Pharmaceutical Services Inc.
                            7.3.13.1. Company overview
                            7.3.13.2. Financial performance
                            7.3.13.3. Product benchmarking
                            7.3.13.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 North America Pharmaceutical Analytical Testing Outsourcing market, by region, 2018 - 2030 (USD Million)
Table 3 North America Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 4 North America Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 5 U.S. Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 6 U.S. Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 7 Canada Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 8 Canada Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 9 Europe Pharmaceutical Analytical Testing Outsourcing market, by region, 2018 - 2030 (USD Million)
Table 10 Europe Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 11 Europe Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 12 UK Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 13 UK Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 14 Germany Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 15 Germany Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 16 France Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 17 France Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 18 Italy Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 19 Italy Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 20 Spain Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 21 Spain Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 22 Denmark Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 23 Denmark Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 24 Sweden Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 25 Sweden Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 26 Norway Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 27 Norway Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 28 Asia Pacific Pharmaceutical Analytical Testing Outsourcing market, by region, 2018 - 2030 (USD Million)
Table 29 Asia Pacific Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 30 Asia Pacific Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 31 China Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 32 China Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 33 India Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 34 India Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 35 Japan Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 36 Japan Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 37 Australia Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 38 Australia Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 39 South Korea Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 40 South Korea Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 41 Thailand Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 42 Thailand Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 43 Latin America Pharmaceutical Analytical Testing Outsourcing market, by region, 2018 - 2030 (USD Million)
Table 44 Latin America Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 45 Latin America Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 46 Brazil Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 47 Brazil Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 48 Mexico Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 49 Mexico Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 50 Argentina Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 51 Argentina Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 52 MEA Pharmaceutical Analytical Testing Outsourcing market, by region, 2018 - 2030 (USD Million)
Table 53 MEA Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 54 MEA Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 55 South Africa Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 56 South Africa Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 59 UAE Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 60 UAE Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 61 Kuwait Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 62 Kuwait Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Pharmaceutical Analytical Testing Outsourcing market: market outlook
Fig. 14 Pharmaceutical Analytical Testing Outsourcing competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Pharmaceutical Analytical Testing Outsourcing market driver impact
Fig. 20 Pharmaceutical Analytical Testing Outsourcing market restraint impact
Fig. 21 Pharmaceutical Analytical Testing Outsourcing market strategic initiatives analysis
Fig. 22 Pharmaceutical Analytical Testing Outsourcing market: Services movement analysis
Fig. 23 Pharmaceutical Analytical Testing Outsourcing market: Services outlook and key takeaways
Fig. 24 Bioanalytical Testing market estimates and forecast, 2018- 2030
Fig. 25 Clinical market estimates and forecast, 2018- 2030
Fig. 26 Non-clinical market estimates and forecast, 2018- 2030
Fig. 27 Method Development & Validation market estimates and forecast, 2018- 2030
Fig. 28 Extractable & Leachable market estimates and forecast, 2018- 2030
Fig. 29 Impurity Method market estimates and forecast, 2018- 2030
Fig. 30 Technical Consulting market estimates and forecast, 2018- 2030
Fig. 31 Others market estimates and forecast, 2018- 2030
Fig. 32 Stability Testing market estimates and forecast, 2018- 2030
Fig. 33 Drug Substance market estimates and forecast, 2018- 2030
Fig. 34 Stability Indicating Method Validation market estimates and forecast, 2018- 2030
Fig. 35 Accelerated Stability Testing market estimates and forecast, 2018- 2030
Fig. 36 Photostability Testing market estimates and forecast, 2018- 2030
Fig. 37 Others market estimates and forecast, 2018- 2030
Fig. 38 Others market estimates and forecast, 2018- 2030
Fig. 39 Pharmaceutical Analytical Testing Outsourcing Market: End-use movement Analysis
Fig. 40 Pharmaceutical Analytical Testing Outsourcing market: End-use outlook and key takeaways
Fig. 41 Pharmaceutical Companies market estimates and forecasts, 2018- 2030
Fig. 42 Biopharmaceutical Companies market estimates and forecasts, 2018- 2030
Fig. 43 Contract Research Organizations market estimates and forecasts, 2018- 2030
Fig. 44 Global Pharmaceutical Analytical Testing Outsourcing market: Regional movement analysis
Fig. 45 Global Pharmaceutical Analytical Testing Outsourcing market: Regional outlook and key takeaways
Fig. 46 Global Pharmaceutical Analytical Testing Outsourcing market share and leading players
Fig. 47 North America market share and leading players
Fig. 48 Europe market share and leading players
Fig. 49 Asia Pacific market share and leading players
Fig. 50 Latin America market share and leading players
Fig. 51 Middle East & Africa market share and leading players
Fig. 52 North America: SWOT
Fig. 53 Europe SWOT
Fig. 54 Asia Pacific SWOT
Fig. 55 Latin America SWOT
Fig. 56 MEA SWOT
Fig. 57 North America, by country
Fig. 58 North America
Fig. 59 North America market estimates and forecasts, 2018- 2030
Fig. 60 U.S.
Fig. 61 U.S. market estimates and forecasts, 2018- 2030
Fig. 62 Canada
Fig. 63 Canada market estimates and forecasts, 2018- 2030
Fig. 64 Europe
Fig. 65 Europe market estimates and forecasts, 2018- 2030
Fig. 66 UK
Fig. 67 UK market estimates and forecasts, 2018- 2030
Fig. 68 Germany
Fig. 69 Germany market estimates and forecasts, 2018- 2030
Fig. 70 France
Fig. 71 France market estimates and forecasts, 2018- 2030
Fig. 72 Italy
Fig. 73 Italy market estimates and forecasts, 2018- 2030
Fig. 74 Spain
Fig. 75 Spain market estimates and forecasts, 2018- 2030
Fig. 76 Denmark
Fig. 77 Denmark market estimates and forecasts, 2018- 2030
Fig. 78 Sweden
Fig. 79 Sweden market estimates and forecasts, 2018- 2030
Fig. 80 Norway
Fig. 81 Norway market estimates and forecasts, 2018- 2030
Fig. 82 Asia Pacific
Fig. 83 Asia Pacific market estimates and forecasts, 2018- 2030
Fig. 84 China
Fig. 85 China market estimates and forecasts, 2018- 2030
Fig. 86 Japan
Fig. 87 Japan market estimates and forecasts, 2018- 2030
Fig. 88 India
Fig. 89 India market estimates and forecasts, 2018- 2030
Fig. 90 Thailand
Fig. 91 Thailand market estimates and forecasts, 2018- 2030
Fig. 92 South Korea
Fig. 93 South Korea market estimates and forecasts, 2018- 2030
Fig. 94 Australia
Fig. 95 Australia market estimates and forecasts, 2018- 2030
Fig. 96 Latin America
Fig. 97 Latin America market estimates and forecasts, 2018- 2030
Fig. 98 Brazil
Fig. 99 Brazil market estimates and forecasts, 2018- 2030
Fig. 100 Mexico
Fig. 101 Mexico market estimates and forecasts, 2018- 2030
Fig. 102 Argentina
Fig. 103 Argentina market estimates and forecasts, 2018- 2030
Fig. 104 Middle East and Africa
Fig. 105 Middle East and Africa market estimates and forecasts, 2018- 2030
Fig. 106 South Africa
Fig. 107 South Africa market estimates and forecasts, 2018- 2030
Fig. 108 Saudi Arabia
Fig. 109 Saudi Arabia market estimates and forecasts, 2018- 2030
Fig. 110 UAE
Fig. 111 UAE market estimates and forecasts, 2018- 2030
Fig. 112 Kuwait
Fig. 113 Kuwait market estimates and forecasts, 2018- 2030
Fig. 114 Market share of key market players- Pharmaceutical Analytical Testing Outsourcing market

Market Segmentation

• Pharmaceutical Analytical Testing Outsourcing Service Outlook (Revenue, USD Million, 2018 - 2030)
  • Bioanalytical Testing
    • Clinical
    • Non-Clinical
  • Method Development & Validation
    • Extractable & Leachable
    • Impurity Method
    • Technical Consulting
    • Others
  • Stability Testing
    • Drug Substance
    • Stability Indicating Method Validation
    • Accelerated Stability Testing
    • Photostability Testing
    • Others
  • Others

• Pharmaceutical Analytical Testing Outsourcing End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Contract Research Organizations
• Pharmaceutical Analytical Testing Outsourcing Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • North America Pharmaceutical analytical testing outsourcing market, By Services
      • Bioanalytical Testing
        • Clinical
        • Non-Clinical
      • Method Development & Validation
        • Extractable & Leachable
        • Impurity Method
        • Technical Consulting
        • Others
      • Stability Testing
        • Drug Substance
        • Stability Indicating Method Validation
        • Accelerated Stability Testing
        • Photostability Testing
        • Others
      • Others
    • North America Pharmaceutical analytical testing outsourcing market, By End-use
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Contract Research Organizations
    • U.S.
      • U.S. Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • U.S. Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations
    • Canada
      • Canada Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • Canada Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations
  • Europe
    • Europe Pharmaceutical analytical testing outsourcing market, By Services
      • Bioanalytical Testing
        • Clinical
        • Non-Clinical
      • Method Development & Validation
        • Extractable & Leachable
        • Impurity Method
        • Technical Consulting
        • Others
      • Stability Testing
        • Drug Substance
        • Stability Indicating Method Validation
        • Accelerated Stability Testing
        • Photostability Testing
        • Others
      • Others
    • Europe Pharmaceutical analytical testing outsourcing market, By End-use
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Contract Research Organizations
    • U.K.
      • U.K. Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • U.K. Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations
    • Germany
    • Germany Pharmaceutical analytical testing outsourcing market, By Services
      • Bioanalytical Testing
        • Clinical
        • Non-Clinical
      • Method Development & Validation
        • Extractable & Leachable
        • Impurity Method
        • Technical Consulting
        • Others
      • Stability Testing
        • Drug Substance
        • Stability Indicating Method Validation
        • Accelerated Stability Testing
        • Photostability Testing
        • Others
      • Others
    • Germany Pharmaceutical analytical testing outsourcing market, By End-use
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Contract Research Organizations
    • France
      • France Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
  • France Pharmaceutical analytical testing outsourcing market, By End-use
    • Pharmaceutical Companies
    • Biopharmaceutical Companies
    • Contract Research Organizations
  • Italy
    • Italy Pharmaceutical analytical testing outsourcing market, By Services
      • Bioanalytical Testing
        • Clinical
        • Non-Clinical
      • Method Development & Validation
        • Extractable & Leachable
        • Impurity Method
        • Technical Consulting
        • Others
      • Stability Testing
        • Drug Substance
        • Stability Indicating Method Validation
        • Accelerated Stability Testing
        • Photostability Testing
        • Others
      • Others
    • Italy Pharmaceutical analytical testing outsourcing market, By End-use
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Contract Research Organizations
  • Spain
    • Spain Pharmaceutical analytical testing outsourcing market, By Services
      • Bioanalytical Testing
        • Clinical
        • Non-Clinical
      • Method Development & Validation
        • Extractable & Leachable
        • Impurity Method
        • Technical Consulting
        • Others
      • Stability Testing
        • Drug Substance
        • Stability Indicating Method Validation
        • Accelerated Stability Testing
        • Photostability Testing
        • Others
      • Others
    • Spain Pharmaceutical analytical testing outsourcing market, By End-use
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Contract Research Organizations
  • Denmark
    
    • Denmark Pharmaceutical analytical testing outsourcing market, By Services
      • Bioanalytical Testing
        • Clinical
        • Non-Clinical
      • Method Development & Validation
        • Extractable & Leachable
        • Impurity Method
        • Technical Consulting
        • Others
      • Stability Testing
        • Drug Substance
        • Stability Indicating Method Validation
        • Accelerated Stability Testing
        • Photostability Testing
        • Others
      • Others
    • Denmark Pharmaceutical analytical testing outsourcing market, By End-use
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Contract Research Organizations
  • Sweden
    
    • Sweden Pharmaceutical analytical testing outsourcing market, By Services
      • Bioanalytical Testing
        • Clinical
        • Non-Clinical
      • Method Development & Validation
        • Extractable & Leachable
        • Impurity Method
        • Technical Consulting
        • Others
      • Stability Testing
        • Drug Substance
        • Stability Indicating Method Validation
        • Accelerated Stability Testing
        • Photostability Testing
        • Others
      • Others
    • Sweden Pharmaceutical analytical testing outsourcing market, By End-use
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Contract Research Organizations
  • Norway
    
    • Norway Pharmaceutical analytical testing outsourcing market, By Services
      • Bioanalytical Testing
        • Clinical
        • Non-Clinical
      • Method Development & Validation
        • Extractable & Leachable
        • Impurity Method
        • Technical Consulting
        • Others
      • Stability Testing
        • Drug Substance
        • Stability Indicating Method Validation
        • Accelerated Stability Testing
        • Photostability Testing
        • Others
      • Others
    • Norway Pharmaceutical analytical testing outsourcing market, By End-use
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Contract Research Organizations
  • Asia Pacific
    • Asia Pacific Pharmaceutical analytical testing outsourcing market, By Services
      • Bioanalytical Testing
        • Clinical
        • Non-Clinical
      • Method Development & Validation
        • Extractable & Leachable
        • Impurity Method
        • Technical Consulting
        • Others
      • Stability Testing
        • Drug Substance
        • Stability Indicating Method Validation
        • Accelerated Stability Testing
        • Photostability Testing
        • Others
      • Others
    • Asia Pacific Pharmaceutical analytical testing outsourcing market, By End-use
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Contract Research Organizations
    • Japan
      • Japan Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • Japan Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations
    • China
      • China Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • China Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations
    • India
      • India Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • India Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations
    • Australia
      • Australia Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • Australia Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations
    • South Korea
      • South Korea Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • South Korea Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations
    • Thailand
      • Thailand Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • Thailand Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations
  • Latin America
    • Latin America Pharmaceutical analytical testing outsourcing market, By Services
      • Bioanalytical Testing
        • Clinical
        • Non-Clinical
      • Method Development & Validation
        • Extractable & Leachable
        • Impurity Method
        • Technical Consulting
        • Others
      • Stability Testing
        • Drug Substance
        • Stability Indicating Method Validation
        • Accelerated Stability Testing
        • Photostability Testing
        • Others
      • Others
    • Latin America Pharmaceutical analytical testing outsourcing market, By End-use
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Contract Research Organizations
    • Brazil
      • Brazil Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • Brazil Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations
    • Mexico
      • Mexico Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • Mexico Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations
    • Argentina
      • Argentina Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • Argentina Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations
  • MEA
    • MEA Pharmaceutical analytical testing outsourcing market, By Services
      • Bioanalytical Testing
        • Clinical
        • Non-Clinical
      • Method Development & Validation
        • Extractable & Leachable
        • Impurity Method
        • Technical Consulting
        • Others
      • Stability Testing
        • Drug Substance
        • Stability Indicating Method Validation
        • Accelerated Stability Testing
        • Photostability Testing
        • Others
      • Others
    • MEA Pharmaceutical analytical testing outsourcing market, By End-use
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Contract Research Organizations
    • South Africa
      • South Africa Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • South Africa Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations
    • Saudi Arabia
      • Saudi Arabia Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • Saudi Arabia Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations
    • UAE
      • UAE Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • UAE Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations
    • Kuwait
      
      • Kuwait Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • Kuwait Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations

Pharmaceutical Analytical Testing Outsourcing Market Dynamics

Driver: Increasing pace of innovations and product development

Innovation and new product development is directly related to the demand for testing services. Due to competitive pressures, pricing concerns, and lead-time to market, companies are preferring outsourcing of testing services. Increasing focus on customized care and technological advancements have reduced the product lifecycle, leading to rapid development of new products. Development of biosimilars, combination products, and other innovative medicines has led to increased demand for specific test types. Moreover, when companies expand their business to a new location, it is mandatory to follow local standards, which may require them to conduct particular types of tests. Outsourcing companies are helping in strategizing systematic approaches to simplify the automation required in analytical instruments. It also increases the speed to market products along with innovative thinking.

Moreover, the use of automation technology has also helped in the development of new drugs by expediting the process without affecting drug quality. In this process, data recording is performed and everything in an experiment is recorded so that the experiment is accurate & repeatable. The use of new technologies has also become fast and they help in organizing & saving data. Increasing R&D investments is a critical sustainability strategy. Not all companies have an infrastructure compatible for all types of analytical testing. Hence, outsourcing these operations is the most suitable option, which also helps save time and costs. In recent years, the R&D expense to total revenue ratio is increasing and expected to continue to rise through 2030.

Driver: Growing safety and quality regulation demand

Increase in complexity and number of standards, which a single product may have to comply with, is driving strong growth in the pharmaceutical analytical testing services outsourcing industry. In addition, companies are required to stay updated with regulatory guidelines and avail expertise & advisory services to be in synchronization with evolving standards. Moreover, organizations such as the International Council for Harmonization (ICH) give harmonized guidelines that are regularly updated. These guidelines are provided so that proper testing, application, and safety of the pharmaceutical product is performed before approving it for human use.

Stringent regulations issued by global regulatory authorities, such as FDA guidelines for clinical trials during the COVID-19 outbreak, Clinical Laboratory Improvement Amendments (CLIA) laboratory regulations, and Good Laboratory Practice (GLP) laboratory regulation, along with increased demand for developing safe & effective therapies and vaccines against SARS-CoV-2, are anticipated to increase the scrutiny on laboratory testing. Testing regulations in Australia are handled by National Measurement Institute (NMI) pertaining to pharmaceutical analysis services, which helps manufacturers in attaining the desired safety level that is appropriate for human use. Increasing awareness about product quality, environmental issues, and safety among consumers is driving companies to outsource tests to ensure that the product complies with aforementioned aspects, thereby building a brand image and enhancing its reputation.

Restraint: Lack of data security

There is always a bilateral information exchange between the client and analytical testing firm involved in the process of analytical testing outsourcing. Several times, clients may have to share confidential information with testing firms, which entails a threat of misuse of this confidential information. If there is no legitimate contract about information security and privacy, it may lead to discrepancies among both parties, hampering mutual trust. For instance, the consultant’s brand image may get affected or the client may have to compromise on security of confidential data.

The attack on data disturbs the process and also delays drug development process. The shared data is very sensitive and can put lives at risk. This data has to be protected effectively, which can be achieved by implementing strong network security. However, this cannot be relied on alone, so there is a need to understand the risks and vulnerabilities within as well as of third-party sources that will help in building resilient data security that would be difficult to breach. Many multinational and small pharmaceutical players are hesitant to opt for consulting services due to the fear of breach of secure information. However, in the future, this situation is expected to change as consulting firms are proactively undertaking initiatives for information protection.

What Does This Report Include?

This section will provide insights into the contents included in this pharmaceutical analytic testing outsourcing market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Pharmaceutical analytical testing outsourcing market qualitative analysis

• Industry overview

• Industry trends

• Market drivers and restraints

• Market size

• Growth prospects

• Porter’s analysis

• PESTEL analysis

• Key market opportunities prioritized

• Competitive landscape

  • Company overview

  • Financial performance

  • Product benchmarking

  • Latest strategic developments

Pharmaceutical analytical testing outsourcing market quantitative analysis

• Market size, estimates, and forecast from 2018 to 2030

• Market estimates and forecast for product segments up to 2030

• Regional market size and forecast for product segments up to 2030

• Market estimates and forecast for application segments up to 2030

• Regional market size and forecast for application segments up to 2030

• Company financial performance